Preview

Oncohematology

Advanced search

Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review

https://doi.org/10.17650/1818-8346-2024-19-2-75-82

Abstract

Diffuse large B-cell lymphoma is the most common immunomorphological variant of lymphoma in adults. Extranodal lesions are observed in a third of patients at the disease onset. The organs most often involved are the gastrointestinal tract, testicles, bones, thyroid gland, and skin. Primary involvement of the nasal cavity and paranasal sinuses occur extremely rarely and cause diagnostic and therapeutic difficulties.

The article demonstrates a rare clinical case of newly diagnosed diffuse large B-cell lymphoma with sinonasal tract involvement. It took 6 months to verify the final diagnosis. At the moment, the induction stage of treatment for diffuse large B-cell lymphoma continues, the achieved complete metabolic response is maintained.

About the Authors

M. A. Mingalimov
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

Marat A. Mingalimov.

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991



E. A. Baryakh
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991; Build. 1, 2/1 Barrikadnaya St., Moscow 125993; 1 Ostrovityanova St., Moscow 117997



O. L. Kochneva
City Clinical Hospital No. 52, Moscow Healthcare Department
Russian Federation

3 Pekhotnaya St., Moscow 123182



E. N. Misyurina
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991



Yu. Yu. Polyakov
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991



E. I. Zhelnova
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991



K. V. Yatskov
City Clinical Hospital No. 52, Moscow Healthcare Department
Russian Federation

3 Pekhotnaya St., Moscow 123182



A. B. Makeshova
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991



T. N. Tolstykh
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991



T. S. Chudnova
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991



D. D. Ivanova
City Clinical Hospital No. 52, Moscow Healthcare Department
Russian Federation

3 Pekhotnaya St., Moscow 123182



D. V. Lebedev
State Scientific Center of the Russian Federation – A.I. Burnazyan Federal Medical Biophysical Center, Federal Medical and Biological Agency
Russian Federation

23 Marshala Novikova St., Moscow 123098



E. N. Zotina
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991



D. E. Gagloeva
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991



M. M. Beregov
Federal Center of Brain Research and Neurotechnologies, Federal Medical and Biological Agency
Russian Federation

Build. 10, 1 Ostrovityanova St., Moscow 117513



E. A. Mamatturdiev
Russian University of Medicine, Ministry of Health of Russia
Russian Federation

4 Dolgorukovskaya St., Moscow 127006



I. V. Samsonova
City Clinical Hospital No. 52, Moscow Healthcare Department
Russian Federation

3 Pekhotnaya St., Moscow 123182



M. A. Lysenko
City Clinical Hospital No. 52, Moscow Healthcare Department
Russian Federation

3 Pekhotnaya St., Moscow 123182



References

1. Chiu B.C., Hou N. Epidemiology and etiology of non-hodgkin lymphoma. Cancer Treat Res 2015;165:1–25. DOI: 10.1007/978-3-319-13150-4_1

2. Evans L.S., Hancock B.W. Non-Hodgkin lymphoma. Lancet 2003;362(9378):139–46. DOI: 10.1016/S0140-6736(03)13868-8

3. Peng K.A., Kita A.E., Suh J.D. et al. Sinonasal lymphoma: case series and review of the literature. Int Forum Allergy Rhinol 2014;4(8):670–4. DOI: 10.1002/alr.21337

4. Vidal R.W., Devaney K., Rinaldo A. et al. Sinonasal malignant lymphomas: a distinct clinicopathological category. Ann Otol Rhinol Laryngol 1999;108(4):411–9. DOI: 10.1177/000348949910800417

5. Perry A.M., Diebold J., Nathwani B.N. et al. Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project. Haematologica 2016;101(10):1244–50. DOI: 10.3324/haematol.2016.148809

6. Yang L., Cui Y., Du X., Tan B. Diffuse large B-cell lymphoma of the frontal sinus: a case report. Ear Nose Throat J 2022:1455613221101089. DOI: 10.1177/01455613221101089.

7. Khan N.R., Lakičević G., Callihan T.R. et al. Diffuse large B-cell lymphoma of the frontal sinus presenting as a pott puffy tumor: case report. J Neurol Surg Rep 2015;76(1):e23–7. DOI: 10.1055/s-0034-1543996

8. Suzuki J., Harazaki Y., Morita S. et al. Myeloid sarcoma of the paranasal sinuses in a patient with acute myeloid leukemia. Tohoku J Exp Med 2018;246(2):141–6. DOI: 10.1620/tjem.246.141

9. Dalmia D., Behera S.K., Bhatia J.S.S. Non-Hodgkin lymphoma of sinuses and nasal cavity: case series of two. Int J Otorhinolaryngol Head Neck Surg 2017;3:737–41. DOI: 10.18203/issn.2454-5929.ijohns20173059

10. Yang J., Wen L., Jin C., Liu Y. Primary diffuse large B-cell lymphoma of the ethmoid sinus: a case report. Ear Nose Throat J 2014;93(8):8–10. DOI: 10.1177/014556131409300819

11. Laveaux K., Axiotis C.A., Durkin H., Braverman A.S. Localized nasal cavity, sinus, and massive bilateral orbital involvement by human T cell leukemia virus 1 adult T cell lymphoma, with epidermal hypertrophy due to mite infestation. Rare Tumors 2010;2(4):e59. DOI: 10.4081/rt.2010.e59

12. Chen C.S., Miller N.R., Lane A., Eberhart C. Third cranial nerve palsy caused by intracranial extension of a sinoorbital natural killer T-cell lymphoma. J Neuroophthalmol 2008;28(1):31–5. DOI: 10.1097/WNO.0b013e3181674228

13. Chang B.H., Chen Y.L., Lee T.J. et al. Paranasal sinus involvement in acute lymphoblastic leukemia. Chang Gung Med J 2004;27(12):924–9.

14. Salplahta D., Comănescu M.V., Anghelina F. et al. Non-Hodgkin lymphomas of Waldeyer’s ring. Rom J Morphol Embryol 2012;53(4):1057–60.

15. Huang Y., Jia B., Jiang S. et al. Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma. J Hematol Oncol 2017;10(1):7. DOI: 10.1186/s13045-016-0368-9

16. Hatta C., Ogasawara H., Okita J. et al. Non-Hodgkin’s malignant lymphoma of the sinonasal tract – treatment outcome for 53 patients according to REAL classification. Auris Nasus Larynx 2001;28(1):55–60. DOI: 10.1016/s0385-8146(00)00094-8

17. Quraishi M.S., Bessell E.M., Clark D. et al. Non-Hodgkin’s lymphoma of the sinonasal tract. Laryngoscope 2000;110(9): 1489–92. DOI: 10.1097/00005537-200009000-00015

18. Venugopal M., Sagesh M. Proptosis: the ENT surgeon’s perspective. Indian J Otolaryngol 2013;65(Suppl 2):247–50. DOI: 10.1007/s12070-011-0367-7


Review

For citations:


Mingalimov M.A., Baryakh E.A., Kochneva O.L., Misyurina E.N., Polyakov Yu.Yu., Zhelnova E.I., Yatskov K.V., Makeshova A.B., Tolstykh T.N., Chudnova T.S., Ivanova D.D., Lebedev D.V., Zotina E.N., Gagloeva D.E., Beregov M.M., Mamatturdiev E.A., Samsonova I.V., Lysenko M.A. Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review. Oncohematology. 2024;19(2):75-82. (In Russ.) https://doi.org/10.17650/1818-8346-2024-19-2-75-82

Views: 1603


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)